AHF Targets Gilead on Drug Pricing @ Baird Global Healthcare Conference
In less than two years, Gilead has more than doubled the cost of its HIV medication, Descovy, for the lifesaving 340B program from $445.11 in Q3, 2020 to $987.55 in Q2, 2022 AHF will host a protest Wednesday, Sept. 14th targeting Gilead Sciences—”Greediad”—and its investors over its AIDS drug pricing during the Baird Global Healthcare … [Read more…]
